Fiscal Cliff Stock Report: Groupon Inc, Cellceutix Corporation, World Moto, Oracle Corporation
NEW YORK, December 26, 2012 /PRNewswire/ --
The Stock Freak has a team of well diverse market professionals that has combined experience of over 30 years that today are providing members with a quick research report on 4 companies.
Groupon Inc (NASDAQ: GRPN) - Groupon, Inc. Operates as a local commerce marketplace that connects merchants to consumers by offering goods and services at a discount in North America and internationally. The Company has had a notable insider trade. On Dec 20th 2012 CFO Jason Child bought 65,000 shares for a total cost of $311,350.00
Whether bull or bear The Stock Freak has got you covered! Sign up to receive our free newsletters and stay up to date with stocks on the run. http://www.TheStockFreak.com
Cellceutix Corporation(OTC:CTIX) Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease. Cellceutix had over 1 million shares traded on Monday and the stock closed up 18%. The Company just recently publicly commented on a New York Times written article about p 53 drugs as the new age In cancer research. CEO of Cellceutix goes on to say that "The New York Times may have overlooked Cellceutix and Kevetrin, but the organizations that are contacting us to host and sponsor clinical trials certainly have not."
World Moto (OTC:FARE) World Moto Still continues to be one of the most active stocks in the OTC markets. The stock traded close to 6 million shares on Monday and closed up nearly 20%. The company also announced that it has selected SVI as Its Manufacturing Partner for the Moto-Meter.
Oracle Corporation (NASDAQ: INTC) - On Dec 17 2012 Chairman of Intel Corporation Andy Bryant bought 2,083. - Correction- On Dec 21 st The Stock Freak released an article stating that Paul Otellini Presdient and CEO of INTC Sold 150,000 shares. The correct and accurate information is that those shares were donated.
To find similar research reports that are available for free follow the link below and sign up at http://www.TheStockFreak.com
Disclosure: TheStockFreak.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. The Stock Freak is a wholly owned entity of a financial public relations firm. Please read our report and visit our website, for complete risks and disclosures.